Psychedelic drugs: neurobiology and potential for treatment of psychiatric disordersFranz X. Vollenweider, Katrin H. Preller2020-09-14reviewNature reviews. Neuroscience568 citationsclosedNo readable copy stored yet — this record is metadata only.Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionAbstractNo abstract was published for this record.Citations in this libraryStored only when both papers are in the corpus — 568 citations exist upstream.References2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2011Neural mechanisms of the cognitive model of depression2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study2004Cortical midline structures and the self2014The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs2004HallucinogensCited by2023Psychedelics promote plasticity by directly binding to BDNF receptor TrkB2022Towards an understanding of psychedelic-induced neuroplasticity2022The neural basis of psychedelic action2021Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics2022Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review2021A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain2021Models of psychedelic drug action: modulation of cortical-subcortical circuits2022Awe as a Pathway to Mental and Physical Health